Correlation Between Sprint Bioscience and Stille AB

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Sprint Bioscience and Stille AB at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sprint Bioscience and Stille AB into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sprint Bioscience AB and Stille AB, you can compare the effects of market volatilities on Sprint Bioscience and Stille AB and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sprint Bioscience with a short position of Stille AB. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sprint Bioscience and Stille AB.

Diversification Opportunities for Sprint Bioscience and Stille AB

-0.14
  Correlation Coefficient

Good diversification

The 3 months correlation between Sprint and Stille is -0.14. Overlapping area represents the amount of risk that can be diversified away by holding Sprint Bioscience AB and Stille AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Stille AB and Sprint Bioscience is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sprint Bioscience AB are associated (or correlated) with Stille AB. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Stille AB has no effect on the direction of Sprint Bioscience i.e., Sprint Bioscience and Stille AB go up and down completely randomly.

Pair Corralation between Sprint Bioscience and Stille AB

Assuming the 90 days trading horizon Sprint Bioscience AB is expected to under-perform the Stille AB. In addition to that, Sprint Bioscience is 2.18 times more volatile than Stille AB. It trades about -0.06 of its total potential returns per unit of risk. Stille AB is currently generating about -0.05 per unit of volatility. If you would invest  21,400  in Stille AB on September 13, 2024 and sell it today you would lose (600.00) from holding Stille AB or give up 2.8% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Sprint Bioscience AB  vs.  Stille AB

 Performance 
       Timeline  
Sprint Bioscience 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Sprint Bioscience AB are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite somewhat uncertain basic indicators, Sprint Bioscience sustained solid returns over the last few months and may actually be approaching a breakup point.
Stille AB 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Stille AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Stille AB is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.

Sprint Bioscience and Stille AB Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Sprint Bioscience and Stille AB

The main advantage of trading using opposite Sprint Bioscience and Stille AB positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sprint Bioscience position performs unexpectedly, Stille AB can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Stille AB will offset losses from the drop in Stille AB's long position.
The idea behind Sprint Bioscience AB and Stille AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.

Other Complementary Tools

Money Managers
Screen money managers from public funds and ETFs managed around the world
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like